Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Anthony J Cmelak
Affiliation
Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
ORCID
Career Start Year
1997
Papers
116
H Index
41
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
38079590
Chemoimmunotherapy for Untreated Lung Cancer Brain Metastases: Systemic Before Local Therapy?
J Clin Oncol
2024
34653954
Impact of COVID-19 on presentation, staging, and treatment of head and neck mucosal squamous cell carcinoma.
Am J Otolaryngol
2022
35504501
The Use of Low-Dose Radiation Therapy in Osteoarthritis: A Review.
Int J Radiat Oncol Biol Phys
2022
35595157
Noninvasive Capsulotomy for Refractory Depression by Frameless Stereotactic Radiosurgery.
Int J Radiat Oncol Biol Phys
2022
35483066
Validity Testing of the Head and Neck Lymphedema and Fibrosis Symptom Inventory.
Lymphat Res Biol
2022
35125231
In reply to: Impact of COVID-19 on head and neck mucosal squamous cell carcinoma: Correspondence.
Am J Otolaryngol
2022
35150023
Management of postradiation late hemorrhage following treatment for HPV-positive oropharyngeal squamous cell carcinoma.
Head Neck
2022
35276673
NCCN Guidelines® Insights: Head and Neck Cancers, Version 1.2022.
J Natl Compr Canc Netw
2022
34454047
Noninvasive Thalamotomy for Refractory Tremor by Frameless Radiosurgery.
Int J Radiat Oncol Biol Phys
2022
32660391
Contemporary Management of Jugular Paragangliomas With Neural Preservation.
Otolaryngol Head Neck Surg
2021
34631230
Effects of cone versus multi-leaf collimation on dosimetry and neurotoxicity in patients with small arteriovenous malformations treated by stereotactic radiosurgery.
J Radiosurg SBRT
2021
34715657
Targeting for stereotactic radiosurgical thalamotomy based on tremor treatment response.
J Neurosurg
2021
34043410
Treatment De-intensification for HPV-Positive Oropharynx Cancer: What Is Currently Acceptable?
J Clin Oncol
2021
34149025
Diameter-Based Volumetric Models May Inadequately Calculate Jugular Paraganglioma Volume Following Sub-Total Resection.
Otol Neurotol
2021
34306917
Stereotactic Radiosurgery and Hypofractionated Stereotactic Radiotherapy for Nonfunctioning Pituitary Adenoma.
J Neurol Surg B Skull Base
2021
34306912
Progressive Vestibular Schwannoma following Subtotal or Near-Total Resection: Dose-Escalated versus Standard-Dose Salvage Stereotactic Radiosurgery.
J Neurol Surg B Skull Base
2021
33068688
Refinement and Validation of the Head and Neck Lymphedema and Fibrosis Symptom Inventory.
Int J Radiat Oncol Biol Phys
2021
33122499
Chronic Electroconvulsive Therapy May Induce Calvarial Hyperemia and Marrow Replacement.
J ECT
2021
33229880
Transient Subacute Facial Nerve Dysfunction After Dual Modality Treatment of Large Vestibular Schwannomas.
Otol Neurotol
2021
32271262
Radiotherapy and Radiosurgery for Treatment of Residual or Recurrent Endolymphatic Sac Tumor Following Previous Microsurgical Resection.
Otol Neurotol
2020
31789966
Long-term Outcomes for the Treatment of Paragangliomas in the Upfront, Adjuvant, and Salvage Settings With Stereotactic Radiosurgery and Intensity-modulated Radiotherapy.
Otol Neurotol
2020
31789797
Current Volumetric Models Overestimate Vestibular Schwannoma Size Following Stereotactic Radiosurgery.
Otol Neurotol
2020
33353553
ECOG-ACRIN 2399: analysis of patient related outcomes after Chemoradiation for locally advanced head and neck Cancer.
Cancers Head Neck
2020
32717053
Improved Cerebral Arteriovenous Malformation Obliteration With 3-Dimensional Rotational Digital Subtraction Angiography for Radiosurgical Planning: A Retrospective Cohort Study.
Neurosurgery
2020
32634781
Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
2020
32770612
Preventive use of gabapentin to decrease pain and systemic symptoms in patients with head and neck cancer undergoing chemoradiation.
Head Neck
2020
32185088
Secondary malignancy following stereotactic radiosurgery for benign neurologic disease: A cohort study and review of the literature.
J Radiosurg SBRT
2020
32185084
Body mass index and response to stereotactic radiosurgery in the treatment of refractory trigeminal neuralgia: A retrospective cohort study.
J Radiosurg SBRT
2020
32500007
Longitudinal Radiographic Outcomes of Vestibular Schwannoma in Single and Fractionated Stereotactic Radiosurgery: A Retrospective Cohort Study.
J Neurol Surg B Skull Base
2020
31552580
Outcomes of stereotactic radiosurgery and hypofractionated stereotactic radiotherapy for refractory Cushing's disease.
Pituitary
2019
31215628
A Retrospective Cohort Study of Longitudinal Audiologic Assessment in Single and Fractionated Stereotactic Radiosurgery for Vestibular Schwannoma.
Neurosurgery
2019
31529045
In Reply: A Retrospective Cohort Study of Longitudinal Audiologic Assessment in Single and Fractionated Stereotactic Radiosurgery for Vestibular Schwannoma.
Neurosurgery
2019
29411506
A simple technique to improve calculated skin dose accuracy in a commercial treatment planning system.
J Appl Clin Med Phys
2018
30241193
Evolving Treatment Paradigms for Oropharyngeal Squamous Cell Carcinoma.
J Glob Oncol
2018
29752322
NCCN Guidelines Insights: Head and Neck Cancers, Version 1.2018.
J Natl Compr Canc Netw
2018
28029303
E1308: Phase II Trial of Induction Chemotherapy Followed by Reduced-Dose Radiation and Weekly Cetuximab in Patients With HPV-Associated Resectable Squamous Cell Carcinoma of the Oropharynx- ECOG-ACRIN Cancer Research Group.
J Clin Oncol
2017
28488066
A phase I trial of concurrent sorafenib and stereotactic radiosurgery for patients with brain metastases.
J Neurooncol
2017
28086954
A comparative analysis between sequential boost and integrated boost intensity-modulated radiation therapy with concurrent chemotherapy for locally-advanced head and neck cancer.
Radiat Oncol
2017
28430530
Reply to A. Garden et al.
J Clin Oncol
2017
28430529
Purpose of Induction Chemotherapy in E1308 and Importance of Patient-Reported Outcomes in Deintensification Trials.
J Clin Oncol
2017
29218301
Long-term Outcomes after Salvage Stereotactic Radiosurgery (SRS) following In-Field Failure of Initial SRS for Brain Metastases.
Front Oncol
2017
28596256
NCCN Guidelines Insights: Head and Neck Cancers, Version 2.2017.
J Natl Compr Canc Netw
2017
28656127
Postoperative Fractionated Stereotactic Radiosurgery to the Tumor Bed for Surgically Resected Brain Metastases.
Cureus
2017
27720703
Margin of error for a frameless image guided radiosurgery system: Direct confirmation based on posttreatment MRI scans.
Pract Radiat Oncol
2017
26944270
Radiotherapy-induced hemichorea.
Neurology
2016
27305456
A Prospective Study of the Lymphedema and Fibrosis Continuum in Patients with Head and Neck Cancer.
Lymphat Res Biol
2016
27178519
Initial radiographic tumor control is similar following single or multi-fractionated stereotactic radiosurgery for jugular paragangliomas.
Am J Otolaryngol
2016
27419843
Establishing quality indicators for neck dissection: Correlating the number of lymph nodes with oncologic outcomes (NRG Oncology RTOG 9501 and RTOG 0234).
Cancer
2016
27227341
Internal Lymphedema Correlates with Subjective and Objective Measures of Dysphagia in Head and Neck Cancer Patients.
J Palliat Med
2016
26705063
A phase I study afatinib/carboplatin/paclitaxel induction chemotherapy followed by standard chemoradiation in HPV-negative or high-risk HPV-positive locally advanced stage III/IVa/IVb head and neck squamous cell carcinoma.
Oral Oncol
2016
1 - 50 of 116
Column Actions
Search
Recommended Authors
Jason W Chan
University of California San Francisco
Career Start Year
2017
Number of shared co-authors
2
Musaddiq J Awan
Medical College of Wisconsin
Career Start Year
2013
Number of shared co-authors
3
Melvin L K Chua
National Cancer Centre Singapore
Career Start Year
2011
Number of shared co-authors
4
Katharine A Price
Mayo Clinic
Career Start Year
2008
Number of shared co-authors
4
Daniel J Ma
Mayo Clinic
Career Start Year
2005
Number of shared co-authors
3
Shao Hui Huang
Princess Margaret Cancer Centre/University Health Network, University of Toronto
Career Start Year
2004
Number of shared co-authors
5
Nadeem Riaz
Memorial Sloan Kettering Cancer Center
Career Start Year
2004
Number of shared co-authors
6
Ezra E W Cohen
university of california san diego Health System
Career Start Year
2001
Number of shared co-authors
12
Clifton D Fuller
The University of Texas MD Anderson Cancer Center
Career Start Year
2001
Number of shared co-authors
7
David A Palma
University of Western Ontario
Career Start Year
2000
Number of shared co-authors
4
Sana D Karam
University of Colorado School of Medicine
Career Start Year
2000
Number of shared co-authors
3
Michelle Alonso-Basanta
Perelman School of Medicine, University of Pennsylvania
Career Start Year
2000
Number of shared co-authors
0
Chiaojung Jillian Tsai
Memorial Sloan Kettering Cancer Center
Career Start Year
2000
Number of shared co-authors
4
Beth M Beadle
Stanford University
Career Start Year
1999
Number of shared co-authors
7
Eric J Sherman
Memorial Sloan Kettering Cancer Center
Career Start Year
1999
Number of shared co-authors
8
Frank J P Hoebers
Maastricht University Medical Centre
Career Start Year
1999
Number of shared co-authors
4
Richard J Wong
Memorial Sloan Kettering Cancer Center
Career Start Year
1998
Number of shared co-authors
8
Steve E Braunstein
University of California san francisco
Career Start Year
1998
Number of shared co-authors
0
Christopher U Jones
Sutter Medical Center Sacramento
Career Start Year
1998
Number of shared co-authors
9
Coen R N Rasch
Leiden University Medical Center
Career Start Year
1997
Number of shared co-authors
1
Helen A Shih
Massachusetts General Hospital and Harvard Medical School
Career Start Year
1997
Number of shared co-authors
0
Stephen Y Lai
The University of Texas MD Anderson Cancer Center
Career Start Year
1995
Number of shared co-authors
6
John H Suh
Taussig Cancer Institute, Cleveland Clinic
Career Start Year
1994
Number of shared co-authors
2
John Waldron
University of Toronto, Princess Margaret Cancer Centre, University Health Network
Career Start Year
1993
Number of shared co-authors
7
Charles R Thomas
Oregon Health & Science University
Career Start Year
1990
Number of shared co-authors
1
Danielle Van den Weyngaert
University of Antwerp
Career Start Year
1987
Number of shared co-authors
1
Lisa Licitra
Fondazione IRCCS Istituto Nazionale dei Tumori and University of Milan
Career Start Year
1987
Number of shared co-authors
6
Johannes H A M Kaanders
Radboud University Medical Center
Career Start Year
1987
Number of shared co-authors
2
Andrzej Niemierko
Massachusetts General Hospital
Career Start Year
1982
Number of shared co-authors
1
John P Kirkpatrick
Duke University Medical Center
Career Start Year
1978
Number of shared co-authors
0
row(s) 1 - 30 of 30
Collaborators
Alexander D Sherry
University of Texas MD Anderson Cancer Center
Co-authored papers
19
Mohamed H Khattab
Vanderbilt University Medical Center
Co-authored papers
18
Guozhen Luo
Vanderbilt University Medical Center
Co-authored papers
16
Robert I Haddad
Dana-Farber Cancer Institute, Harvard Medical School
Co-authored papers
11
David G Pfister
Memorial Sloan Kettering Cancer Center
Co-authored papers
10
Lola B Chambless
Vanderbilt University School of Medicine
Co-authored papers
10
Mary S Dietrich
Vanderbilt University School of Nursing
Co-authored papers
10
Wendell G Yarbrough
University of North Carolina at Chapel Hill
Co-authored papers
9
Antonio Jimeno
University of Colorado School of Medicine
Co-authored papers
6
Cristina Rodr??guez-Antona
Spanish National Cancer Research Center (CNIO)
Co-authored papers
6
Robert L Foote
Mayo Clinic
Co-authored papers
5
Nancy Wells
College of Human Ecology, Cornell University
Co-authored papers
5
Austin N Kirschner
Vanderbilt University Medical Center
Co-authored papers
5
Robbert J C Slebos
Co-authored papers
4
Eddy S Yang
University of Alabama at Birmingham, O'Neal Comprehensive Cancer Center
Co-authored papers
4
Joel S Parker
Lineberger Cancer Center, University of North Carolina
Co-authored papers
3
Kenneth A Wallston
Vanderbilt University Medical Center
Co-authored papers
3
Hong Yu
Vanderbilt University Medical Center
Co-authored papers
3
Alexander Langerman
Vanderbilt University Medical Center
Co-authored papers
3
Shawn Levy
HudsonAlpha Institute for Biotechnology
Co-authored papers
3
Fenna T Phibbs
Vanderbilt University Medical Center
Co-authored papers
3
Joseph S Neimat
University of Louisville
Co-authored papers
3
Peter Hedera
University of Louisville
Co-authored papers
2
Christopher D Willey
University of Alabama at Birmingham
Co-authored papers
2
William H Westra
Icahn School of Medicine at Mount Sinai Hospital.
Co-authored papers
2
David I Rosenthal
MD Anderson Cancer Center
Co-authored papers
2
Rohan Chitale
Vanderbilt University Medical Center
Co-authored papers
2
Michael Henke
Medical Center, University of Freiburg
Co-authored papers
2
Adel K El-Naggar
MD Anderson Cancer Center
Co-authored papers
1
Eric Winquist
Schulich School of Medicine and Dentistry, University of Western Ontario
Co-authored papers
1
1 - 30